Influence of D-cycloserine on the anticonvulsant activity of phenytoin and carbamazepine against electroconvulsions in mice

Epilepsia

Volumn 37, Issue 7, 1996, Pages 610-617

  Wlaź, Piotr ^a,c   Roliński, Zbigniew ^a   Czuczwar, Stanislaw J ^b  

^a UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Anticonvulsants; Carbamazepine; D Cycloserine; Maximal electroshock seizures; Mice; Phenytoin

Indexed keywords

CARBAMAZEPINE; CYCLOSERINE; PHENYTOIN;

AMNESIA; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG POTENTIATION; ELECTRIC SHOCK; FLUORESCENCE POLARIZATION IMMUNOASSAY; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM MEMORY; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SEIZURE THRESHOLD; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTICONVULSANTS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CARBAMAZEPINE; CYCLOSERINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ELECTROSHOCK; EPILEPSY; HUMANS; MALE; MEMORY; MICE; MOTOR ACTIVITY; PHENYTOIN; SEIZURES;

EID: 0029893645     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb00624.x     Document Type: Article

References (54)

1. Dingledine R, McBain CJ, McNamara JO. Excitatory amino acid receptors in epilepsy. Trends Pharmacol Sci 1990;11: 334-8.
2. Robinson MB, Coyle JT. Glutamate and related acidic excitatory neurotransmitters: from basic science to clinical applications. FASEB J 1987;1:446-55.
3. Scatton B. The NMDA complex. Fundam Clin Pharmacol 1993;7:389-400.
4. Croucher MJ, Collins JF, Meldrum BS. Anticonvulsant action of excitatory amino acids antagonists. Science 1982;216:899-901.
5. Czuczwar SJ, Janusz W, Wamil A, Kleinrok Z. Inhibition of aminophylline-induced convulsions in mice by antiepileptic drugs and other agents. Eur J Pharmacol 1987;144:309-15.
6. Czuczwar SJ, Meldrum BS. Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid. Eur J Pharmacol 1982;83:335-8.
7. Schmutz M, Portet C, Jeker A. el al. The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally active anticonvulsants in rodents. Naunyn-Schmiede-bergs Arch Pharmacol 1990;342:61-6.
8. Wlaź P, Baran H, Löscher W. Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice. Eur J Pharmacol 1994;257:217-25.
9. Zarnowski T, Kleinrok Z, Turski WA, Czuczwar SJ. The competitive NMDA antagonist, D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice. Neuropharmacology 1994;33:619-24.
10. Löscher W, Hönack D. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy: comparison with MK-801 and carbamazepine. J Pharmacol Exp Ther 1991;256:432-40.
11. McNamara JO, Russell RD. Rigsbee L, Bonhaus DW. Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models. Neuropharmacology 1988;27:563-8.
12. Porter RJ. Mechanisms of action of new antiepileptic drugs. Epilepsia 1989;(suppl 1):S29-34.
13. Sveinbjornsdottir S, Sander JWAS, Upton D, et al. The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res 1993;16:165-74.
14. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987;325:529-31.
15. Kleckner NW, Dingledine R. Requirement for glycine in activation of N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines. Science 1988;241:835-7.
16. Baran H, Löscher W, Mevissen M. The glycine/NMDA receptor partial agonist D-cycloserine blocks kainate-induced seizures in rats: comparison with MK-801 and diazepam. Brain Res 1994;652:195-200.
17. Koek W, Colpaert FC. Selective blockade of N-methyl-Daspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationships with phencyclidine-like behavioral effects. J Pharmacol Exp Ther 1990;252:349-57.
18. Lange P, Oehme P. Zentralnervöse Wirkungen von D- und D,L-Cycloserin. Arch Int Pharmacodyn Ther 1964;152:466-73.
19. Mayer O, Jankl, Kršiak M. Die zentralen Wirkungen des Cycloserin im Tierexperiment. Arzneimittelforschung 1971;21:298-303.
20. Peterson SL. 7-Chlorokynurenic acid antagonizes the anticonvulsant activity of D-cycloserine in maximal electroshock seizures. Epilepsy Res 1992;13:73-81.
21. Smith SE, Meldrum BS. The glycine site NMDA receptor antagonist, R-(+)-cis-beta-methyl-3-amino-1-hydroxypyrrolid-2-one, L-687,414 is anticonvulsant in baboons. Eur J Pharmacol 1992;211:109-11.
22. Croucher MJ, Bradford HF. The influence of strychnine-insensitive glycine receptor agonists and antagonists on generalized seizure thresholds. Brain Res 1991;543:91-6.
23. Croucher MJ, Bradford HF. 7-Chlorokynurenic acid, a strychnine-insensitive glycine receptor antagonist, inhibits limbic seizure kindling. Neurosci Lett 1990;118:29-32.
24. Löscher W, Wlaź P, Rundfeldt C, Baran H, Hönack D. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats. Br J Pharmacol 1994;112:97-106.
25. Hood WF, Compton RP, Monahan JB. D-Cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics. Neurosci Lett 1989;98:91-5.
26. Watson GB, Bolanowski MA, Baganoff MP, Deppler CL, Lanthorn TH. D-Cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes. Brain Res 1990;510:158-60.
27. Peterson SL, Schwade ND. The anticonvulsant activity of D-cycloserine is specific for tonic convulsions. Epilepsy Res 1993;15:141-8.
28. Meador KJ. Cognitive side effects of antiepileptic drugs. Can J Neurol Sci 1994;21:12-6.
29. Löscher W, Nolting B, Fassbender CP. The role of technical, biological, and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. I. The influence of administration vehicles. Epilepsy Res 1990;7:173-81.
30. Kimball AW, Burnett WT, Doherty DG. Chemical protection against ionizing radiation: sampling methods for screening compounds in radiation protection studies with mice. Radiat Res 1957;7:1-12.
31. Löscher W, Fassbender CP, Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res 1991;8:79-94.
32. Wlaź P, Roliński Z, Kleinrok Z, Czuczwar SJ. Influence of chronic aminophylline on the anticonvulsant efficacy of phenobarbital and valproate in mice. Epilepsia 1993;34:385-9.
33. Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949;96:99-113.
34. Boissier J-R, Tardy J, Diverres J-C. Une nouvelle méthode simple pour explerer l'action tranquilisante: le test de la cheminée. Med Exp 1960;3:81-4.
35. Wlaź P, Ebert U, Löscher W. Low doses of the glycine/NMDA receptor antagonist R-(+)-HA-966 but not D-cycloserine induce paroxysmal activity in limbic brain regions of kindled rats. Eur J Neurosci 1994;6:1710-9.
36. Tettenborn D. Experimental pharmacology and toxicology of antituberculosis drugs. In: Bartmann K, ed. Antituberculosis drugs. Berlin: Springer-Verlag, 1988:307-98.
37. Rundfeldt C, Wlaź P, Löscher W. Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy. Brain Res 1994;653:125-30.
38. Von Lubitz DKJE, Lin RC-S, McKenzie RJ, Devlin TM, McCabe RT, Skolnick P. A novel treatment of ischemia with a glycine partial agonist. Eur J Pharmacol 1992;219:53-8.
39. Peterson SL. Anticonvulsant drug potentiation by glycine in maximal electroshock seizures is mimicked by D-serine and antagonized by 7-chlorokynurenic acid. Eur J Pharmacol 1991;199:341-8.
40. Baran H, Gramer M, Löscher W. Alterations in plasma and brain amino acids after administration of the glycine/NMDA receptor partial agonist, D-cycloserine, to mice and rats. Eur J Pharmacol 1995;273:197-201.
41. Wamil AW, McLean MJ. Phenytoin blocks N-methyl-Daspartate responses of mouse central neurons. J Pharmacol Exp Ther 1993;267:218-27.
42. Kawano H, Sashihara S, Mita T, Ohno K, Kawamura M, Yoshii K. Phenytoin, an antiepileptic drug, competitively blocked non-NMDA receptors produced by Xenopus oocytes. Neurosci Lett 1994;166:183-6.
43. Collingridge GL, Bliss TVP. NMDA receptors-their role in long term potentiation. Trends Neurosci 1987;10:288-93.
44. Baxter MG, Lanthorn TH, Frick KM, Golski S, Wan RQ, Olton DS. D-Cycloserine, a novel cognitive enhancer, improves spatial memory in aged rats. Neurobiol Aging 1994;15:207-13.
45. Flood JF, Morley JE, Lanthorn TH. Effect on memory processing by D-cycloserine, an agonist of the NMDA/glycine receptor. Eur J Pharmacol 1992;221:249-54.
46. Sirviö J, Ekonsalo T, Riekkinen P Jr, Lahtinen H, Riekkinen P Sr. D-Cycloserine, a modulator of the N-methyl-D-aspartate receptor, improves spatial learning in rats treated with muscarinic antagonist. Neurosci Lett 1992;146:215-8.
47. De Noble VJ, Jones KW, Schaffer CL, Bauerle LM. CPP and PCP produce amnesia of a passive avoidance response in rats. Soc Neurosci Abstr 1989;15:1166.
48. Walker DL, Gold PE. Effects of the novel NMDA antagonist, NPC 12626, on long-term potentiation, learning and memory. Brain Res 1991;549:213-21.
49. Xu XJ, Klinger P, Davis R. Comparative anterograde amnes- tic and anticonvulsant effects of two types of NMDA receptor antagonists: MK-801 and HA-966. Psychopharmacology 1995;117:333-9.
50. Monahan JB, Handelmann GE, Hood WF, Cordi AA. DCycloserine, a positive modulator of the N-methyl-D-aspartate receptor, enhances performance of learning tasks in rats. Pharmacol Biochem Behav 1989;34:649-53.
51. Fishkin RJ, Ince ES, Carlezon WAJ, Dunn RW. D-Cycloserine attenuates scopolamine-induced learning and memory deficits in rats. Behav Neural Biol 1993;59:150-7.
52. Randolph C, Roberts JW, Tierney MC, Bravi D, Mouradian MM, Chase TN. D-Cycloserine treatment of Alzheimer disease. Alzheimer Dis Assoc Disord 1994;8:198-205.
53. Rupniak NMJ, Duchnowski M, Tye SJ, Cook G, Iversen SD. Failure of D-cycloserine to reverse cognitive disruption induced by scopolamine or phencyclidine in primates. Life Sci 1992;50:1959-62.
54. Weinstein L. Antimicrobial agents. In: Goodman LS, Gilman A, eds. The pharmacological basis of therapeutics. New York: Macmillan, 1975:1201-23.